These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24209622)

  • 1. Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.
    Emerling BM; Hurov JB; Poulogiannis G; Tsukazawa KS; Choo-Wing R; Wulf GM; Bell EL; Shim HS; Lamia KA; Rameh LE; Bellinger G; Sasaki AT; Asara JM; Yuan X; Bullock A; Denicola GM; Song J; Brown V; Signoretti S; Cantley LC
    Cell; 2013 Nov; 155(4):844-57. PubMed ID: 24209622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of PI5P4Kα/β disrupts cell energy metabolism and selectively kills p53-null tumor cells.
    Chen S; Chandra Tjin C; Gao X; Xue Y; Jiao H; Zhang R; Wu M; He Z; Ellman J; Ha Y
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.
    Ma G; Duan Y; Huang X; Qian CX; Chee Y; Mukai S; Cui J; Samad A; Matsubara JA; Kazlauskas A; D'Amore PA; Gu S; Lei H
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3935-43. PubMed ID: 27472081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding role of PI5P4Ks in cancer: A promising druggable target.
    Arora GK; Palamiuc L; Emerling BM
    FEBS Lett; 2022 Jan; 596(1):3-16. PubMed ID: 34822164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
    Yang H; Shu Z; Jiang Y; Mao W; Pang L; Redwood A; Jeter-Jones SL; Jennings NB; Ornelas A; Zhou J; Rodriguez-Aguayo C; Bartholomeusz G; Iles LR; Zacharias NM; Millward SW; Lopez-Berestein G; Le XF; Ahmed AA; Piwnica-Worms H; Sood AK; Bast RC; Lu Z
    Clin Cancer Res; 2019 Sep; 25(18):5702-5716. PubMed ID: 31391192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.
    Wortmann L; Bräuer N; Holton SJ; Irlbacher H; Weiske J; Lechner C; Meier R; Karén J; Siöberg CB; Pütter V; Christ CD; Ter Laak A; Lienau P; Lesche R; Nicke B; Cheung SH; Bauser M; Haegebarth A; von Nussbaum F; Mumberg D; Lemos C
    J Med Chem; 2021 Nov; 64(21):15883-15911. PubMed ID: 34699202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localizations of phosphatidylinositol 5-phosphate 4-kinases α and β are dynamic and independently regulated during starvation-induced stress.
    Droubi A; Bulley SJ; Clarke JH; Irvine RF
    Biochem J; 2016 Jul; 473(14):2155-63. PubMed ID: 27208178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
    Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: A role for PIP4K2B in the regulation of E-cadherin expression.
    Keune WJ; Sims AH; Jones DR; Bultsma Y; Lynch JT; Jirström K; Landberg G; Divecha N
    Cancer Res; 2013 Dec; 73(23):6913-25. PubMed ID: 24127122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
    Osman AA; Monroe MM; Ortega Alves MV; Patel AA; Katsonis P; Fitzgerald AL; Neskey DM; Frederick MJ; Woo SH; Caulin C; Hsu TK; McDonald TO; Kimmel M; Meyn RE; Lichtarge O; Myers JN
    Mol Cancer Ther; 2015 Feb; 14(2):608-19. PubMed ID: 25504633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling: a new target for p53-null tumours.
    Lokody I
    Nat Rev Cancer; 2014 Jan; 14(1):8-9. PubMed ID: 24304875
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin.
    Berge EO; Huun J; Lillehaug JR; Lønning PE; Knappskog S
    Biochim Biophys Acta; 2013 Mar; 1830(3):2790-7. PubMed ID: 23246812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
    Gadhikar MA; Sciuto MR; Alves MV; Pickering CR; Osman AA; Neskey DM; Zhao M; Fitzgerald AL; Myers JN; Frederick MJ
    Mol Cancer Ther; 2013 Sep; 12(9):1860-73. PubMed ID: 23839309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.
    Lundquist MR; Goncalves MD; Loughran RM; Possik E; Vijayaraghavan T; Yang A; Pauli C; Ravi A; Verma A; Yang Z; Johnson JL; Wong JCY; Ma Y; Hwang KS; Weinkove D; Divecha N; Asara JM; Elemento O; Rubin MA; Kimmelman AC; Pause A; Cantley LC; Emerling BM
    Mol Cell; 2018 May; 70(3):531-544.e9. PubMed ID: 29727621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR1 regulates transcription and is required for growth of human cancer cells with
    Fan Y; Yue J; Xiao M; Han-Zhang H; Wang YV; Ma C; Deng Z; Li Y; Yu Y; Wang X; Niu S; Hua Y; Weng Z; Atadja P; Li E; Xiang B
    Elife; 2017 Aug; 6():. PubMed ID: 28767039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer.
    Tesei A; Arienti C; Bossi G; Santi S; De Santis I; Bevilacqua A; Zanoni M; Pignatta S; Cortesi M; Zamagni A; Storci G; Bonafè M; Sarnelli A; Romeo A; Cavallo C; Bartolazzi A; Rossi S; Soriani A; Strigari L
    J Exp Clin Cancer Res; 2021 Mar; 40(1):89. PubMed ID: 33673859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plumbagin from a tropical pitcher plant (Nepenthes alata Blanco) induces apoptotic cell death via a p53-dependent pathway in MCF-7 human breast cancer cells.
    De U; Son JY; Jeon Y; Ha SY; Park YJ; Yoon S; Ha KT; Choi WS; Lee BM; Kim IS; Kwak JH; Kim HS
    Food Chem Toxicol; 2019 Jan; 123():492-500. PubMed ID: 30458268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.
    Noch EK; Yim I; Milner TA; Cantley LC
    J Comp Neurol; 2021 Feb; 529(2):434-449. PubMed ID: 32449185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.